These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12801143)

  • 1. New insight into the analysis of 6-[18F]fluoro-L-DOPA PET dynamic data in brain tissue without an irreversible compartment: comparative study of the Patlak and Logan analyses.
    Kawatsu S; Kato T; Nagano-Saito A; Hatano K; Ito K; Ishigaki T
    Radiat Med; 2003; 21(1):47-54. PubMed ID: 12801143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
    Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
    Rousset OG; Deep P; Kuwabara H; Evans AC; Gjedde AH; Cumming P
    Synapse; 2000 Aug; 37(2):81-9. PubMed ID: 10881028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
    Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
    J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
    Kuwabara H; Cumming P; Yasuhara Y; Léger GC; Guttman M; Diksic M; Evans AC; Gjedde A
    J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.
    Li CT; Palotti M; Holden JE; Oh J; Okonkwo O; Christian BT; Bendlin BB; Buyan-Dent L; Harding SJ; Stone CK; DeJesus OT; Nickles RJ; Gallagher CL
    Synapse; 2014 Aug; 68(8):325-31. PubMed ID: 24710997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PET study using 6-[18F]-fluorodopa in Parkinson's disease].
    Nagasawa H; Tanji H; Itoh M; Itoyama Y
    Nihon Rinsho; 1997 Jan; 55(1):213-7. PubMed ID: 9014452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.
    Hoshi H; Kuwabara H; Léger G; Cumming P; Guttman M; Gjedde A
    J Cereb Blood Flow Metab; 1993 Jan; 13(1):57-69. PubMed ID: 8417011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients.
    Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH
    Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
    Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
    Dimitrakopoulou-Strauss A; Strauss LG; Burger C
    J Nucl Med; 2001 Feb; 42(2):248-56. PubMed ID: 11216523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDOPA kinetics in brain tumors.
    Schiepers C; Chen W; Cloughesy T; Dahlbom M; Huang SC
    J Nucl Med; 2007 Oct; 48(10):1651-61. PubMed ID: 17873130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.
    Nagano-Saito A; Kato T; Arahata Y; Washimi Y; Nakamura A; Abe Y; Yamada T; Iwai K; Hatano K; Kawasumi Y; Kachi T; Dagher A; Ito K
    Neuroimage; 2004 Jun; 22(2):553-61. PubMed ID: 15193583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
    Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
    Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
    Brück A; Aalto S; Nurmi E; Bergman J; Rinne JO
    Neurobiol Aging; 2005 Jun; 26(6):891-8. PubMed ID: 15718048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.